Global Next Generation Antibody Therapeutics Market Growth (Status and Outlook) 2025-2031

April 2025 | 109 pages | ID: G3F9115E6C42EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Medical Vacuum Regulator market size is predicted to grow from US$ 166 million in 2025 to US$ 235 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.

Medical Vacuum Regulator is a medical device that converts the high-pressure vacuum that is supplied by the hospitals central vacuum system to a safe level for use on a patient.

The vacuum regulator is used to measure and adjust the vacuum level within the context of medical suction. It enables to drain substances out of the patient’s body during surgical procedures. The vacuum regulator should be connected to a vacuum source on the wall either using a direct probe or a rail mounting system. It should be associated with a collection jar and a suction hose.

Global Medical Vacuum Regulator key players include Ohio Medical, Amico, Precision Medical, Air Liquid Healthcare, Integral, etc. Global top five manufacturers hold a share about 35%.

North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, having a total share about 55 percent.

In terms of product, Analog Vacuum Regulator is the largest segment, with a share about 70%. And in terms of application, the largest application is in Clinical, followed by Surgical.

LP Information, Inc. (LPI) ' newest research report, the “Medical Vacuum Regulator Industry Forecast” looks at past sales and reviews total world Medical Vacuum Regulator sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Vacuum Regulator sales for 2025 through 2031. With Medical Vacuum Regulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Vacuum Regulator industry.

This Insight Report provides a comprehensive analysis of the global Medical Vacuum Regulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Vacuum Regulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Vacuum Regulator market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Vacuum Regulator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Vacuum Regulator.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Vacuum Regulator market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Analog Vacuum Regulator
• Digital Vacuum Regulator

Segmentation by Application:

• Clinically
• Surgical

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Ohio Medical
• Amico
• Precision Medical
• Air Liquid Healthcare
• Integral
• Allied Healthcare Products
• Shanghai Amcaremed Technology
• Acare
• Hersill

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Vacuum Regulator market?

What factors are driving Medical Vacuum Regulator market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Vacuum Regulator market opportunities vary by end market size?

How does Medical Vacuum Regulator break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Next Generation Antibody Therapeutics Market Size (2020-2031)
  2.1.2 Next Generation Antibody Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Next Generation Antibody Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Next Generation Antibody Therapeutics Segment by Type
  2.2.1 Antibody Drug Conjugate (ADC)
  2.2.2 Bispecific Antibody (BsAb)
2.3 Next Generation Antibody Therapeutics Market Size by Type
  2.3.1 Next Generation Antibody Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Next Generation Antibody Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Next Generation Antibody Therapeutics Segment by Application
  2.4.1 Cancer
  2.4.2 Haemophilia
  2.4.3 Other Non-Cancer Diseases
2.5 Next Generation Antibody Therapeutics Market Size by Application
  2.5.1 Next Generation Antibody Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Next Generation Antibody Therapeutics Market Size Market Share by Application (2020-2025)

3 NEXT GENERATION ANTIBODY THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Next Generation Antibody Therapeutics Market Size Market Share by Player
  3.1.1 Global Next Generation Antibody Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Next Generation Antibody Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Next Generation Antibody Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NEXT GENERATION ANTIBODY THERAPEUTICS BY REGION

4.1 Next Generation Antibody Therapeutics Market Size by Region (2020-2025)
4.2 Global Next Generation Antibody Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Next Generation Antibody Therapeutics Market Size Growth (2020-2025)
4.4 APAC Next Generation Antibody Therapeutics Market Size Growth (2020-2025)
4.5 Europe Next Generation Antibody Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Next Generation Antibody Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Next Generation Antibody Therapeutics Market Size by Country (2020-2025)
5.2 Americas Next Generation Antibody Therapeutics Market Size by Type (2020-2025)
5.3 Americas Next Generation Antibody Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Next Generation Antibody Therapeutics Market Size by Region (2020-2025)
6.2 APAC Next Generation Antibody Therapeutics Market Size by Type (2020-2025)
6.3 APAC Next Generation Antibody Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Next Generation Antibody Therapeutics Market Size by Country (2020-2025)
7.2 Europe Next Generation Antibody Therapeutics Market Size by Type (2020-2025)
7.3 Europe Next Generation Antibody Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Next Generation Antibody Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NEXT GENERATION ANTIBODY THERAPEUTICS MARKET FORECAST

10.1 Global Next Generation Antibody Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Next Generation Antibody Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Next Generation Antibody Therapeutics Forecast
  10.1.3 APAC Next Generation Antibody Therapeutics Forecast
  10.1.4 Europe Next Generation Antibody Therapeutics Forecast
  10.1.5 Middle East & Africa Next Generation Antibody Therapeutics Forecast
10.2 Americas Next Generation Antibody Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Next Generation Antibody Therapeutics Forecast
  10.2.2 Canada Market Next Generation Antibody Therapeutics Forecast
  10.2.3 Mexico Market Next Generation Antibody Therapeutics Forecast
  10.2.4 Brazil Market Next Generation Antibody Therapeutics Forecast
10.3 APAC Next Generation Antibody Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Next Generation Antibody Therapeutics Market Forecast
  10.3.2 Japan Market Next Generation Antibody Therapeutics Forecast
  10.3.3 Korea Market Next Generation Antibody Therapeutics Forecast
  10.3.4 Southeast Asia Market Next Generation Antibody Therapeutics Forecast
  10.3.5 India Market Next Generation Antibody Therapeutics Forecast
  10.3.6 Australia Market Next Generation Antibody Therapeutics Forecast
10.4 Europe Next Generation Antibody Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Next Generation Antibody Therapeutics Forecast
  10.4.2 France Market Next Generation Antibody Therapeutics Forecast
  10.4.3 UK Market Next Generation Antibody Therapeutics Forecast
  10.4.4 Italy Market Next Generation Antibody Therapeutics Forecast
  10.4.5 Russia Market Next Generation Antibody Therapeutics Forecast
10.5 Middle East & Africa Next Generation Antibody Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Next Generation Antibody Therapeutics Forecast
  10.5.2 South Africa Market Next Generation Antibody Therapeutics Forecast
  10.5.3 Israel Market Next Generation Antibody Therapeutics Forecast
  10.5.4 Turkey Market Next Generation Antibody Therapeutics Forecast
10.6 Global Next Generation Antibody Therapeutics Forecast by Type (2026-2031)
10.7 Global Next Generation Antibody Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Next Generation Antibody Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche Next Generation Antibody Therapeutics Product Offered
  11.1.3 Roche Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 Amgen
  11.2.1 Amgen Company Information
  11.2.2 Amgen Next Generation Antibody Therapeutics Product Offered
  11.2.3 Amgen Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Amgen Main Business Overview
  11.2.5 Amgen Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer Next Generation Antibody Therapeutics Product Offered
  11.3.3 Pfizer Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 Takeda
  11.4.1 Takeda Company Information
  11.4.2 Takeda Next Generation Antibody Therapeutics Product Offered
  11.4.3 Takeda Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Takeda Main Business Overview
  11.4.5 Takeda Latest Developments
11.5 Daiichi Sankyo
  11.5.1 Daiichi Sankyo Company Information
  11.5.2 Daiichi Sankyo Next Generation Antibody Therapeutics Product Offered
  11.5.3 Daiichi Sankyo Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Daiichi Sankyo Main Business Overview
  11.5.5 Daiichi Sankyo Latest Developments
11.6 Seagen
  11.6.1 Seagen Company Information
  11.6.2 Seagen Next Generation Antibody Therapeutics Product Offered
  11.6.3 Seagen Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Seagen Main Business Overview
  11.6.5 Seagen Latest Developments
11.7 Astellas
  11.7.1 Astellas Company Information
  11.7.2 Astellas Next Generation Antibody Therapeutics Product Offered
  11.7.3 Astellas Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Astellas Main Business Overview
  11.7.5 Astellas Latest Developments
11.8 Immunomedics
  11.8.1 Immunomedics Company Information
  11.8.2 Immunomedics Next Generation Antibody Therapeutics Product Offered
  11.8.3 Immunomedics Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Immunomedics Main Business Overview
  11.8.5 Immunomedics Latest Developments
11.9 GSK
  11.9.1 GSK Company Information
  11.9.2 GSK Next Generation Antibody Therapeutics Product Offered
  11.9.3 GSK Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 GSK Main Business Overview
  11.9.5 GSK Latest Developments
11.10 Immunocore
  11.10.1 Immunocore Company Information
  11.10.2 Immunocore Next Generation Antibody Therapeutics Product Offered
  11.10.3 Immunocore Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Immunocore Main Business Overview
  11.10.5 Immunocore Latest Developments
11.11 ADC Therapeutics
  11.11.1 ADC Therapeutics Company Information
  11.11.2 ADC Therapeutics Next Generation Antibody Therapeutics Product Offered
  11.11.3 ADC Therapeutics Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 ADC Therapeutics Main Business Overview
  11.11.5 ADC Therapeutics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Next Generation Antibody Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Next Generation Antibody Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antibody Drug Conjugate (ADC)
Table 4. Major Players of Bispecific Antibody (BsAb)
Table 5. Next Generation Antibody Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Next Generation Antibody Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Next Generation Antibody Therapeutics Market Size Market Share by Type (2020-2025)
Table 8. Next Generation Antibody Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Next Generation Antibody Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Next Generation Antibody Therapeutics Market Size Market Share by Application (2020-2025)
Table 11. Global Next Generation Antibody Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Next Generation Antibody Therapeutics Revenue Market Share by Player (2020-2025)
Table 13. Next Generation Antibody Therapeutics Key Players Head office and Products Offered
Table 14. Next Generation Antibody Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Next Generation Antibody Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Next Generation Antibody Therapeutics Market Size Market Share by Region (2020-2025)
Table 19. Global Next Generation Antibody Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Next Generation Antibody Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Next Generation Antibody Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Next Generation Antibody Therapeutics Market Size Market Share by Country (2020-2025)
Table 23. Americas Next Generation Antibody Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Next Generation Antibody Therapeutics Market Size Market Share by Type (2020-2025)
Table 25. Americas Next Generation Antibody Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Next Generation Antibody Therapeutics Market Size Market Share by Application (2020-2025)
Table 27. APAC Next Generation Antibody Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Next Generation Antibody Therapeutics Market Size Market Share by Region (2020-2025)
Table 29. APAC Next Generation Antibody Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Next Generation Antibody Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Next Generation Antibody Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Next Generation Antibody Therapeutics Market Size Market Share by Country (2020-2025)
Table 33. Europe Next Generation Antibody Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Next Generation Antibody Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Next Generation Antibody Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Next Generation Antibody Therapeutics
Table 39. Key Market Challenges & Risks of Next Generation Antibody Therapeutics
Table 40. Key Industry Trends of Next Generation Antibody Therapeutics
Table 41. Global Next Generation Antibody Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Next Generation Antibody Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Next Generation Antibody Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Next Generation Antibody Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Roche Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 46. Roche Next Generation Antibody Therapeutics Product Offered
Table 47. Roche Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Roche Main Business
Table 49. Roche Latest Developments
Table 50. Amgen Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 51. Amgen Next Generation Antibody Therapeutics Product Offered
Table 52. Amgen Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Amgen Main Business
Table 54. Amgen Latest Developments
Table 55. Pfizer Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 56. Pfizer Next Generation Antibody Therapeutics Product Offered
Table 57. Pfizer Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Pfizer Main Business
Table 59. Pfizer Latest Developments
Table 60.Takeda Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 61.Takeda Next Generation Antibody Therapeutics Product Offered
Table 62.Takeda Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63.Takeda Main Business
Table 64.Takeda Latest Developments
Table 65. Daiichi Sankyo Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 66. Daiichi Sankyo Next Generation Antibody Therapeutics Product Offered
Table 67. Daiichi Sankyo Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Daiichi Sankyo Main Business
Table 69. Daiichi Sankyo Latest Developments
Table 70. Seagen Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 71. Seagen Next Generation Antibody Therapeutics Product Offered
Table 72. Seagen Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Seagen Main Business
Table 74. Seagen Latest Developments
Table 75. Astellas Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 76. Astellas Next Generation Antibody Therapeutics Product Offered
Table 77. Astellas Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Astellas Main Business
Table 79. Astellas Latest Developments
Table 80. Immunomedics Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 81. Immunomedics Next Generation Antibody Therapeutics Product Offered
Table 82. Immunomedics Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Immunomedics Main Business
Table 84. Immunomedics Latest Developments
Table 85. GSK Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 86. GSK Next Generation Antibody Therapeutics Product Offered
Table 87. GSK Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. GSK Main Business
Table 89. GSK Latest Developments
Table 90. Immunocore Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 91. Immunocore Next Generation Antibody Therapeutics Product Offered
Table 92. Immunocore Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Immunocore Main Business
Table 94. Immunocore Latest Developments
Table 95. ADC Therapeutics Details, Company Type, Next Generation Antibody Therapeutics Area Served and Its Competitors
Table 96. ADC Therapeutics Next Generation Antibody Therapeutics Product Offered
Table 97. ADC Therapeutics Next Generation Antibody Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. ADC Therapeutics Main Business
Table 99. ADC Therapeutics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Next Generation Antibody Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Next Generation Antibody Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Next Generation Antibody Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Next Generation Antibody Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Next Generation Antibody Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Next Generation Antibody Therapeutics Market Size Market Share by Type in 2024
Figure 10. Next Generation Antibody Therapeutics in Cancer
Figure 11. Global Next Generation Antibody Therapeutics Market: Cancer (2020-2025) & ($ millions)
Figure 12. Next Generation Antibody Therapeutics in Haemophilia
Figure 13. Global Next Generation Antibody Therapeutics Market: Haemophilia (2020-2025) & ($ millions)
Figure 14. Next Generation Antibody Therapeutics in Other Non-Cancer Diseases
Figure 15. Global Next Generation Antibody Therapeutics Market: Other Non-Cancer Diseases (2020-2025) & ($ millions)
Figure 16. Global Next Generation Antibody Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Next Generation Antibody Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Next Generation Antibody Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Next Generation Antibody Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Next Generation Antibody Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Next Generation Antibody Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Next Generation Antibody Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Next Generation Antibody Therapeutics Value Market Share by Country in 2024
Figure 24. United States Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Next Generation Antibody Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Next Generation Antibody Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Next Generation Antibody Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Next Generation Antibody Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Next Generation Antibody Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Next Generation Antibody Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Next Generation Antibody Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Next Generation Antibody Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Next Generation Antibody Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Next Generation Antibody Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Next Generation Antibody Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Next Generation Antibody Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Next Generation Antibody Therapeutics Market Size 2026-2031 ($ millions)